Factors associated with pneumococcal polysaccharide vaccination of the elderly in Spain: A cross-sectional study

Angela Domínguez; Núria Soldevila; Diana Toledo; Pere Godoy; Núria Torner; Luis Force; Jesús Castilla; José María Mayoral; Sonia Tamames; Vicente Martín; Mikel Egurrola; Francisco Sanz; Jenaro Astray; null Project PI12/02079 Working Group; J. Díaz-Borrego; A. Morillo; M. J. Pérez-Lozano; J. Gutiérrez; M. Pérez-Ruiz; M. A. Fernández-Sierra; S. Rojo-Rello; R. Ortiz de Lejarazu; M. I. Fernández-Natal; T. Fernández-Villa; A. Pueyo; A. Vilella; A. Antón; G. Navarro; M. Riera; E. Espejo; M. D. Mas; R. Pérez; J. A. Cayla; C. Rius; I. Crespo; C. Izquierdo; R. Torra; M. F. Domínguez-Berjon; M. A. Gutiérrez; S. Jiménez; E. Gil; F. Martín; R. Génova-Maleras; M. C. Prados; F. Ezzine de Blas; J. C. Galan; E. Navas; L. Rodríguez; C. J. Álvarez; E. Banderas; J. Chamorro; I. Casado; J. Díaz; M. J. López de Goicoechea; M. Morales

doi:10.1080/21645515.2016.1149661

Factors associated with pneumococcal polysaccharide vaccination of the elderly in Spain: A cross-sectional study

Angela Domínguez, Núria Soldevila, Diana Toledo, Pere Godoy, Núria Torner, Luis Force, Jesús Castilla, José María Mayoral, Sonia Tamames, Vicente Martín, Mikel Egurrola, Francisco Sanz, Jenaro Astray, Project PI12/02079 Working Group, J. Díaz-Borrego, A. Morillo, M. J. Pérez-Lozano, J. Gutiérrez, M. Pérez-Ruiz, M. A. Fernández-SierraS. Rojo-Rello, R. Ortiz de Lejarazu, M. I. Fernández-Natal, T. Fernández-Villa, A. Pueyo, A. Vilella, A. Antón, G. Navarro, M. Riera, E. Espejo, M. D. Mas, R. Pérez, J. A. Cayla, C. Rius, I. Crespo, C. Izquierdo, R. Torra, M. F. Domínguez-Berjon, M. A. Gutiérrez, S. Jiménez, E. Gil, F. Martín, R. Génova-Maleras, M. C. Prados, F. Ezzine de Blas, J. C. Galan, E. Navas, L. Rodríguez, C. J. Álvarez, E. Banderas, J. Chamorro, I. Casado, J. Díaz, M. J. López de Goicoechea, M. Morales

Departament de Genètica i de Microbiologia

Producció científica: Contribució a revista › Article › Recerca › Avaluat per experts

20 Cites (Scopus)

Resum

© 2016 Taylor & Francis. ABSTRACT: Vaccination of the elderly is an important factor in limiting the impact of pneumonia in the community. The aim of this study was to investigate the factors associated with pneumococcal polysaccharide vaccination in patients aged ≥ 65 years hospitalized for causes unrelated to pneumonia, acute respiratory disease, or influenza-like illness in Spain. We made a cross-sectional study during 2013-2014. A bivariate analysis was performed comparing vaccinated and unvaccinated patients, taking into account sociodemographic variables and risk medical conditions. A multivariate analysis was performed using multilevel regression models. 921 patients were included; 403 (43.8%) had received the pneumococcal vaccine (394 received the polysaccharide vaccine). Visiting the general practitioner ≥ 3 times during the last year (OR = 1.79; 95% CI 1.25-2.57); having received the influenza vaccination in the 2013-14 season (OR = 2.57; 95% CI 1.72-3.84) or in any of the 3 previous seasons (OR = 11.70; 95% CI 7.42-18.45) were associated with receiving the pneumococcal polysaccharide vaccine. Pneumococcal vaccination coverage of hospitalized elderly people is low. The elderly need to be targeted about pneumococcal vaccination and activities that encourage healthcare workers to proactively propose vaccination might be useful. Educational campaigns aimed at the elderly could also help to increase vaccination coverages and reduce the burden of pneumococcal disease in the community.

Idioma original	Anglès
Pàgines (de-a)	1891-1899
Revista	Human Vaccines and Immunotherapeutics
Volum	12
Número	7
DOIs	https://doi.org/10.1080/21645515.2016.1149661
Estat de la publicació	Publicada - 2 de jul. 2016

SDG de les Nacions Unides

Aquest resultat contribueix als següents objectius de desenvolupament sostenible.

Accés al document

10.1080/21645515.2016.1149661

Com citar-ho

Domínguez, A., Soldevila, N., Toledo, D., Godoy, P., Torner, N., Force, L., Castilla, J., Mayoral, J. M., Tamames, S., Martín, V., Egurrola, M., Sanz, F., Astray, J., Project PI12/02079 Working Group, Díaz-Borrego, J., Morillo, A., Pérez-Lozano, M. J., Gutiérrez, J., Pérez-Ruiz, M., ... Morales, M. (2016). Factors associated with pneumococcal polysaccharide vaccination of the elderly in Spain: A cross-sectional study. Human Vaccines and Immunotherapeutics, 12(7), 1891-1899. https://doi.org/10.1080/21645515.2016.1149661

@article{179e502000ce4172ad71ca6a08883a4c,

title = "Factors associated with pneumococcal polysaccharide vaccination of the elderly in Spain: A cross-sectional study",

abstract = "{\textcopyright} 2016 Taylor & Francis. ABSTRACT: Vaccination of the elderly is an important factor in limiting the impact of pneumonia in the community. The aim of this study was to investigate the factors associated with pneumococcal polysaccharide vaccination in patients aged ≥ 65 years hospitalized for causes unrelated to pneumonia, acute respiratory disease, or influenza-like illness in Spain. We made a cross-sectional study during 2013-2014. A bivariate analysis was performed comparing vaccinated and unvaccinated patients, taking into account sociodemographic variables and risk medical conditions. A multivariate analysis was performed using multilevel regression models. 921 patients were included; 403 (43.8%) had received the pneumococcal vaccine (394 received the polysaccharide vaccine). Visiting the general practitioner ≥ 3 times during the last year (OR = 1.79; 95% CI 1.25-2.57); having received the influenza vaccination in the 2013-14 season (OR = 2.57; 95% CI 1.72-3.84) or in any of the 3 previous seasons (OR = 11.70; 95% CI 7.42-18.45) were associated with receiving the pneumococcal polysaccharide vaccine. Pneumococcal vaccination coverage of hospitalized elderly people is low. The elderly need to be targeted about pneumococcal vaccination and activities that encourage healthcare workers to proactively propose vaccination might be useful. Educational campaigns aimed at the elderly could also help to increase vaccination coverages and reduce the burden of pneumococcal disease in the community.",

keywords = "elderly patients, immunization, pneumococcal vaccination, public health, vaccination",

author = "Angela Dom{\'i}nguez and N{\'u}ria Soldevila and Diana Toledo and Pere Godoy and N{\'u}ria Torner and Luis Force and Jes{\'u}s Castilla and Mayoral, {Jos{\'e} Mar{\'i}a} and Sonia Tamames and Vicente Mart{\'i}n and Mikel Egurrola and Francisco Sanz and Jenaro Astray and {Project PI12/02079 Working Group} and J. D{\'i}az-Borrego and A. Morillo and P{\'e}rez-Lozano, {M. J.} and J. Guti{\'e}rrez and M. P{\'e}rez-Ruiz and Fern{\'a}ndez-Sierra, {M. A.} and S. Rojo-Rello and {Ortiz de Lejarazu}, R. and Fern{\'a}ndez-Natal, {M. I.} and T. Fern{\'a}ndez-Villa and A. Pueyo and A. Vilella and A. Ant{\'o}n and G. Navarro and M. Riera and E. Espejo and Mas, {M. D.} and R. P{\'e}rez and Cayla, {J. A.} and C. Rius and I. Crespo and C. Izquierdo and R. Torra and Dom{\'i}nguez-Berjon, {M. F.} and Guti{\'e}rrez, {M. A.} and S. Jim{\'e}nez and E. Gil and F. Mart{\'i}n and R. G{\'e}nova-Maleras and Prados, {M. C.} and {Ezzine de Blas}, F. and Galan, {J. C.} and E. Navas and L. Rodr{\'i}guez and {\'A}lvarez, {C. J.} and E. Banderas and J. Chamorro and I. Casado and J. D{\'i}az and {L{\'o}pez de Goicoechea}, {M. J.} and M. Morales",

year = "2016",

month = jul,

day = "2",

doi = "10.1080/21645515.2016.1149661",

language = "English",

volume = "12",

pages = "1891--1899",

journal = "Human Vaccines and Immunotherapeutics",

issn = "2164-5515",

number = "7",

}

Domínguez, A, Soldevila, N, Toledo, D, Godoy, P, Torner, N, Force, L, Castilla, J, Mayoral, JM, Tamames, S, Martín, V, Egurrola, M, Sanz, F, Astray, J, Project PI12/02079 Working Group, Díaz-Borrego, J, Morillo, A, Pérez-Lozano, MJ, Gutiérrez, J, Pérez-Ruiz, M, Fernández-Sierra, MA, Rojo-Rello, S, Ortiz de Lejarazu, R, Fernández-Natal, MI, Fernández-Villa, T, Pueyo, A, Vilella, A, Antón, A, Navarro, G, Riera, M, Espejo, E, Mas, MD, Pérez, R, Cayla, JA, Rius, C, Crespo, I, Izquierdo, C, Torra, R, Domínguez-Berjon, MF, Gutiérrez, MA, Jiménez, S, Gil, E, Martín, F, Génova-Maleras, R, Prados, MC, Ezzine de Blas, F, Galan, JC, Navas, E, Rodríguez, L, Álvarez, CJ, Banderas, E, Chamorro, J, Casado, I, Díaz, J, López de Goicoechea, MJ & Morales, M 2016, 'Factors associated with pneumococcal polysaccharide vaccination of the elderly in Spain: A cross-sectional study', Human Vaccines and Immunotherapeutics, vol. 12, núm. 7, pàg. 1891-1899. https://doi.org/10.1080/21645515.2016.1149661

TY - JOUR

T1 - Factors associated with pneumococcal polysaccharide vaccination of the elderly in Spain: A cross-sectional study

AU - Domínguez, Angela

AU - Soldevila, Núria

AU - Toledo, Diana

AU - Godoy, Pere

AU - Torner, Núria

AU - Force, Luis

AU - Castilla, Jesús

AU - Mayoral, José María

AU - Tamames, Sonia

AU - Martín, Vicente

AU - Egurrola, Mikel

AU - Sanz, Francisco

AU - Astray, Jenaro

AU - Project PI12/02079 Working Group, null

AU - Díaz-Borrego, J.

AU - Morillo, A.

AU - Pérez-Lozano, M. J.

AU - Gutiérrez, J.

AU - Pérez-Ruiz, M.

AU - Fernández-Sierra, M. A.

AU - Rojo-Rello, S.

AU - Ortiz de Lejarazu, R.

AU - Fernández-Natal, M. I.

AU - Fernández-Villa, T.

AU - Pueyo, A.

AU - Vilella, A.

AU - Antón, A.

AU - Navarro, G.

AU - Riera, M.

AU - Espejo, E.

AU - Mas, M. D.

AU - Pérez, R.

AU - Cayla, J. A.

AU - Rius, C.

AU - Crespo, I.

AU - Izquierdo, C.

AU - Torra, R.

AU - Domínguez-Berjon, M. F.

AU - Gutiérrez, M. A.

AU - Jiménez, S.

AU - Gil, E.

AU - Martín, F.

AU - Génova-Maleras, R.

AU - Prados, M. C.

AU - Ezzine de Blas, F.

AU - Galan, J. C.

AU - Navas, E.

AU - Rodríguez, L.

AU - Álvarez, C. J.

AU - Banderas, E.

AU - Chamorro, J.

AU - Casado, I.

AU - Díaz, J.

AU - López de Goicoechea, M. J.

AU - Morales, M.

PY - 2016/7/2

Y1 - 2016/7/2

N2 - © 2016 Taylor & Francis. ABSTRACT: Vaccination of the elderly is an important factor in limiting the impact of pneumonia in the community. The aim of this study was to investigate the factors associated with pneumococcal polysaccharide vaccination in patients aged ≥ 65 years hospitalized for causes unrelated to pneumonia, acute respiratory disease, or influenza-like illness in Spain. We made a cross-sectional study during 2013-2014. A bivariate analysis was performed comparing vaccinated and unvaccinated patients, taking into account sociodemographic variables and risk medical conditions. A multivariate analysis was performed using multilevel regression models. 921 patients were included; 403 (43.8%) had received the pneumococcal vaccine (394 received the polysaccharide vaccine). Visiting the general practitioner ≥ 3 times during the last year (OR = 1.79; 95% CI 1.25-2.57); having received the influenza vaccination in the 2013-14 season (OR = 2.57; 95% CI 1.72-3.84) or in any of the 3 previous seasons (OR = 11.70; 95% CI 7.42-18.45) were associated with receiving the pneumococcal polysaccharide vaccine. Pneumococcal vaccination coverage of hospitalized elderly people is low. The elderly need to be targeted about pneumococcal vaccination and activities that encourage healthcare workers to proactively propose vaccination might be useful. Educational campaigns aimed at the elderly could also help to increase vaccination coverages and reduce the burden of pneumococcal disease in the community.

AB - © 2016 Taylor & Francis. ABSTRACT: Vaccination of the elderly is an important factor in limiting the impact of pneumonia in the community. The aim of this study was to investigate the factors associated with pneumococcal polysaccharide vaccination in patients aged ≥ 65 years hospitalized for causes unrelated to pneumonia, acute respiratory disease, or influenza-like illness in Spain. We made a cross-sectional study during 2013-2014. A bivariate analysis was performed comparing vaccinated and unvaccinated patients, taking into account sociodemographic variables and risk medical conditions. A multivariate analysis was performed using multilevel regression models. 921 patients were included; 403 (43.8%) had received the pneumococcal vaccine (394 received the polysaccharide vaccine). Visiting the general practitioner ≥ 3 times during the last year (OR = 1.79; 95% CI 1.25-2.57); having received the influenza vaccination in the 2013-14 season (OR = 2.57; 95% CI 1.72-3.84) or in any of the 3 previous seasons (OR = 11.70; 95% CI 7.42-18.45) were associated with receiving the pneumococcal polysaccharide vaccine. Pneumococcal vaccination coverage of hospitalized elderly people is low. The elderly need to be targeted about pneumococcal vaccination and activities that encourage healthcare workers to proactively propose vaccination might be useful. Educational campaigns aimed at the elderly could also help to increase vaccination coverages and reduce the burden of pneumococcal disease in the community.

KW - elderly patients

KW - immunization

KW - pneumococcal vaccination

KW - public health

KW - vaccination

U2 - 10.1080/21645515.2016.1149661

DO - 10.1080/21645515.2016.1149661

M3 - Article

SN - 2164-5515

VL - 12

SP - 1891

EP - 1899

JO - Human Vaccines and Immunotherapeutics

JF - Human Vaccines and Immunotherapeutics

IS - 7

ER -

Factors associated with pneumococcal polysaccharide vaccination of the elderly in Spain: A cross-sectional study

Resum

SDG de les Nacions Unides

Accés al document

Fingerprint

Com citar-ho